Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 431.43B P/E 72.14 EPS this Y 118.40% Ern Qtrly Grth 66.80%
Income 6.14B Forward P/E 42.44 EPS next Y 41.20% 50D Avg Chg 1.00%
Sales 35.93B PEG 0.99 EPS past 5Y -3.09% 200D Avg Chg 19.00%
Dividend 1.00% Price/Book 36.52 EPS next 5Y 56.73% 52W High Chg -3.00%
Recommedations 2.00 Quick Ratio 0.67 Shares Outstanding 0.95B 52W Low Chg 53.00%
Insider Own 0.16% ROA 12.60% Shares Float 898.10M Beta 0.37
Inst Own 84.57% ROE 50.75% Shares Shorted/Prior 5.11M/5.42M Price 454.48
Gross Margin 80.16% Profit Margin 17.08% Avg. Volume 2,662,108 Target Price 856.61
Oper. Margin 31.20% Earnings Date Aug 8 Volume 2,365,805 Change 0.31%
About Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Eli Lilly and Company News
05/11/24 1 No-Brainer Growth Stock to Buy and Hold
05/11/24 Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
05/10/24 Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
05/10/24 How A Top Fund Beats The Market By Owning Future Leaders
05/10/24 Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
05/10/24 Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
05/10/24 UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
05/09/24 Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
05/09/24 3 Stocks to Buy Following Guidance Upgrades
05/09/24 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
05/09/24 Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
05/09/24 Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
05/08/24 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
05/07/24 What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
05/07/24 A Look at Pharma ETFs Post Q1 Earnings
05/07/24 13 Best Stocks That Will Always Grow
05/07/24 Kevin O’Leary’s Stock Portfolio: 10 Stock Picks for 2024
05/07/24 UPDATE 2-US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
05/07/24 Mutual Funds Can't Get Enough Amazon, Broadcom
05/07/24 FDA sets date for advisory meeting on Lilly’s closely watched Alzheimer’s drug
LLY Chatroom

User Image PrecisionSwingTrader Posted - 26 minutes ago

TRADE CLOSED Symbol: $MRK Type: Buy to Cover Return: + 1.68% Entry: 10/18/2022 Adjusted Short: 130.33 Cover: 128.14 Size: 6% Rationale: Closing this position largely because of how stubborn its held this upper range. I still believe the upsloping TL since mid-March will break to the downside & this could be a bigger winner -- but, I simply ran out of time on this trade as I need the capital elsewhere. $NVAX $LLY $PFE $JNJ

User Image BasedPinkWojak Posted - 39 minutes ago

$LLY is now a good entry?

User Image HopefulCass Posted - 42 minutes ago

$LLY $NVO $VKTX This comment 👏

User Image Chartsgalore Posted - 44 minutes ago

$VKTX down $11 or 13% in a day and a half on no news. 50% retracement of this move would be in the $76 area, this stock is capable of making that move quickly. Any reason for $LLY down and $NVO up?

User Image PrecisionSwingTrader Posted - 54 minutes ago

TRADE CLOSED Symbol: $ABIO Type: Sell to Close (Stopped Out) Return: +70.3% Entry: 3/31/2023 Cost: 1.83 Stop: 3.12 Size: 0.2% Algos got me; I feel targeted...stop set at 3.08 just under the consolidation area, and Mr Market pierced it just enough to trigger me for a close at 3.12 -- oh well $NVAX $MRNA $WBA $LLY

User Image BasedPinkWojak Posted - 1 hour ago

$LLY what's going on? is there some kind of news?

User Image 1Kof Posted - 1 hour ago

$LLY lost a lot on this turd!

User Image MF__DOOM Posted - 1 hour ago

$CRSP bulls almost all trapped in the pen $GME $SPY $QQQ $LLY

User Image SayNo2ScamDontVoteDNC Posted - 1 hour ago

$LLY stay tuned. The DOW is flying but this can barely hold anything. Thinking the worse may be yet to come. Many have a big target long term but at present it's overvalued. The MMs have decided to chop this down in the meantime . 700 or less is coming

User Image fishinNbanjo Posted - 2 hours ago

$LLY clearly something is going on here that we don't know about.

User Image fishinNbanjo Posted - 2 hours ago

$LLY fucking wrecked everyday

User Image Keepitmoving Posted - 3 hours ago

$HIMS $LLY $NVO Btw, Novo coming for your asses. Compounders are going to feel the wrath!!!

User Image LieutenantJoe Posted - 5 hours ago

$ELTP $JNJ $LLY

User Image Stocksrockman Posted - 19 hours ago

$WAVD when we started the play, we only had 980 watchers We will break 3,000 by tomorrow Watchers will become slappers tomorrow morning $NVDA still holding above $800 $LLY dipping a bit $WNW nice day Friday $DXYN had a volume spike Friday like WNW

User Image Doozio Posted - 19 hours ago

$lly if it’s gonna get obvious then let’s get obvious it’s 🧠⏰♾️

User Image twincam Posted - 22 hours ago

$LLY … Here’s to the woman who argues with the GPS, and somehow, the GPS ends up apologizing.” Happy Mother’s Day to all Mums 💰💰💰

User Image EFhutton420 Posted - 23 hours ago

$LLY what are the est sales of Donanemab?

User Image EFhutton420 Posted - 23 hours ago

$LLY https://fox59.com/indiana-news/new-lawsuit-filed-in-federal-court-on-new-eli-lilly-and-company-alzheimers-treatment/

User Image EFhutton420 Posted - 23 hours ago

$LLY so if Lilly gets approved, and PDL wins the suit, then Lilly will have to pay PDL an ongoing royalty. Prob low single digits.

User Image LieutenantJoe Posted - 23 hours ago

$ELTP the FDA approval of elite pharmaceutical generic OxyContin will be a total game changer $JNJ $LLY

User Image hypegal25 Posted - 1 day ago

$HIMS giving $LLY a run for its money with its upcoming glp-1 launch 🚀

User Image GexPulse Posted - 1 day ago

$LLY trading near $760, slightly under the 50 SMA of $761.5, indicating a potential pivot point. The price remains well above both the 200 SMA of $638.13 and the Volume POC of $590.51, showcasing significant bullish momentum long-term. Current dynamic support is observed at $749.76, with resistance near the $763.97 level. Gamma exposure is subtle with a gamma flip at $727.5 and a very low Net Gex of 0.01, suggesting that gamma isn't heavily influencing price action for now. The options market is fairly balanced with a put/call ratio of 0.75, but with significant interests at both $750 for calls and $720 for puts. Expected short-term movements are between $749.76 and $770.24, aligning closely with key confluence ranges. These ranges highlight crucial interaction points for the stock, suggesting areas where traders might expect increased activity or pivots. https://twitter.com/GexPulse/status/1789359691643912660?t=d9CUS8_YWiRAgdTfzfclvA&s=19

User Image Carlos1976 Posted - 2 days ago

$LLY when will FDA approve alzeimer drug?

User Image Leaprr Posted - 2 days ago

$LLY Just chopping in a flat base shaking out weak hands. Hourly oversold soon so might get a bounce.

User Image hypegal25 Posted - 2 days ago

$HIMS GLP-1s soon for everyone 👀 $100B industry like $LLY

User Image Cloud875 Posted - 2 days ago

FY2024 EPS Estimates for Rigel Pharmaceuticals, Inc. Lifted by Cantor Fitzgerald $RIGL $LLY https://www.marketbeat.com/instant-alerts/nasdaq-rigl-analyst-earnings-estimates-2024-05-10/

User Image impact80 Posted - 2 days ago

$LLY out hope it drops to $740 now

User Image stocksrream Posted - 2 days ago

$HIMS $LLY $NVO Hims coming for Ozempic and WeGovy, half the price, available to all. Just had a blowout earnings.

User Image Ro_Patel Posted - 2 days ago

$GOOGL DeepMind targeting the $100B+ AI drug discovery business w/ AlphaFold 3 - the first AI-designed drugs may be ready for testing in “next couple of years,” AlphaFold software was developed to predict the 3D structure of proteins & subsequently has received a significant upgrade. It can now model other molecules of biological importance, including DNA, and the interactions b/n antibodies produced by the immune system and the molecules of disease organisms. The software was developed by Google DeepMind and Isomorphic labs, a sibling company under parent Alphabet working on AI for biotech that is also led by Hassabis. In January, Isomorphic Labs announced that it would work with $LLY & $NVO on drug development.

User Image SayNo2ScamDontVoteDNC Posted - 2 days ago

$LLY this thing is ready to go!! No volume or nothing. Fearing the worse that this is gonna really shit the bed with a bad market day. IJS.

Analyst Ratings
BMO Capital Outperform May 1, 24
JP Morgan Overweight May 1, 24
Cantor Fitzgerald Overweight May 1, 24
Truist Securities Buy May 1, 24
Cantor Fitzgerald Overweight Apr 30, 24
Cantor Fitzgerald Overweight Apr 18, 24
Cantor Fitzgerald Overweight Apr 15, 24
Goldman Sachs Neutral Apr 11, 24
Cantor Fitzgerald Overweight Apr 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LILLY ENDOWMENT INC Director Director Jan 16 Sell 645.86 1,180 762,115 99,542,630 01/17/24
LILLY ENDOWMENT INC Director Director Jan 04 Sell 630.65 14,388 9,073,792 99,754,422 01/05/24
LILLY ENDOWMENT INC Director Director Aug 08 Sell 521.62 204,409 106,623,823 100,823,810 08/09/23
LILLY ENDOWMENT INC Director Director Jul 21 Sell 466.621 591 275,773 101,028,219 07/24/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 29 Sell 465.083 44,115 20,517,137 101,192,935 06/30/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 458.99 107,022 49,122,028 101,248,810 06/23/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 21 Sell 454.54 31,454 14,297,101 101,355,832 06/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 15 Sell 454.59 27,353 12,434,400 101,446,457 06/16/23
LILLY ENDOWMENT INC 10% Owner 10% Owner May 19 Sell 444.92 194,354 86,471,982 101,473,810 05/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 367.21 130,297 47,846,361 102,133,810 04/07/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 363.72 69,703 25,352,375 102,264,107 04/06/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 31 Sell 342.71 205,000 70,255,550 102,543,810 04/03/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 02 Sell 372.97 49,089 18,308,724 102,948,810 12/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 01 Sell 373.31 160,911 60,069,685 102,997,899 12/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 07 Sell 364.42 63,585 23,171,646 103,158,810 11/08/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 02 Sell 362.07 6,131 2,219,851 103,357,679 11/03/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 18 Sell 334.29 12,042 4,025,520 103,529,293 10/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 14 Sell 334.42 3,187 1,065,797 103,620,959 10/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 06 Sell 336.56 149,264 50,236,292 103,624,546 10/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Sep 28 Sell 336.99 101,631 34,248,631 103,773,810 09/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 28 Sell 333.18 89,458 29,805,616 103,875,441 07/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 26 Sell 332.524 1,601 532,371 103,964,899 07/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 15 Sell 334 17,310 5,781,540 103,966,500 07/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 06 Sell 330.88 177,243 58,646,164 103,983,810 07/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 28 Sell 329.01 900 296,109 104,161,053 06/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 27 Sell 329.045 41,857 13,772,837 104,161,953 06/28/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 24 Sell 323.95 215,000 69,649,250 104,203,810 06/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 23 Sell 311.37 205,000 63,830,850 104,418,810 06/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 307.35 210,000 64,543,500 104,623,810 06/23/22
Zakrowski Donald A Chief Accounting Off.. Chief Accounting Officer Jun 01 Sell 313.44 1,000 313,440 6,274 06/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 25 Sell 309.36 41,610 12,872,470 105,212,200 05/26/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 24 Sell 306.01 100,000 30,601,000 105,253,810 05/25/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 23 Sell 303.37 118,856 36,057,345 105,353,810 05/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 18 Sell 302.00 700 211,400 105,472,666 05/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 17 Sell 302.73 19,683 5,958,635 105,473,366 05/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 16 Sell 302.75 80,761 24,450,393 105,493,049 05/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 08 Sell 310.88 139,045 43,226,310 105,573,810 04/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 301.11 51,851 15,612,855 105,783,810 04/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 294.4 113,756 33,489,766 105,835,661 04/06/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 04 Sell 293.152 39,393 11,548,137 105,949,417 04/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 30 Sell 292.03 2,500 730,075 106,154,186 03/31/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 28 Sell 292.155 7,538 2,202,264 106,161,027 03/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 18 Sell 288.4 210,000 60,564,000 106,203,810 03/21/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 17 Sell 283.95 220,000 62,469,000 106,413,810 03/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 15 Sell 273.77 220,075 60,249,933 106,633,810 03/16/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 14 Sell 269.73 173,085 46,686,217 106,853,885 03/15/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 11 Sell 269.047 21,840 5,875,986 107,026,970 03/14/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 10 Sell 266.8 184,982 49,353,198 107,048,810 03/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 09 Sell 266.94 20,018 5,343,605 107,233,792 03/10/22
Runge Marschall S Director Director Mar 01 Buy 246.78 202 49,850 15,436 03/07/22